Works matching Investigational therapies


Results: 1656
    1

    Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats.

    Published in:
    Veterinary & Comparative Oncology, 2021, v. 19, n. 2, p. 311, doi. 10.1111/vco.12677
    By:
    • LeBlanc, Amy K.;
    • Atherton, Matthew;
    • Bentley, R. Timothy;
    • Boudreau, C. Elizabeth;
    • Burton, Jenna H.;
    • Curran, Kaitlin M.;
    • Dow, Steven;
    • Giuffrida, Michelle A.;
    • Kellihan, Heidi B.;
    • Mason, Nicola J.;
    • Oblak, Michelle;
    • Selmic, Laura E.;
    • Selting, Kimberly A.;
    • Singh, Ameet;
    • Tjostheim, Sonja;
    • Vail, David M.;
    • Weishaar, Kristen M.;
    • Berger, Erika P.;
    • Rossmeisl, John H.;
    • Mazcko, Christina
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Four cases of investigational therapy with interleukin-11 against acute myocardial infarction.

    Published in:
    Heart & Vessels, 2016, v. 31, n. 9, p. 1574, doi. 10.1007/s00380-015-0788-4
    By:
    • Nakagawa, Masashi;
    • Owada, Yasuko;
    • Izumi, Yasukatsu;
    • Nonin, Shinichi;
    • Sugioka, Kenichi;
    • Nakatani, Daisaku;
    • Iwata, Shinichi;
    • Mizutani, Kazuki;
    • Nishimura, Satoshi;
    • Ito, Asahiro;
    • Fujita, Suwako;
    • Daimon, Takashi;
    • Sawa, Yoshiki;
    • Asakura, Masanori;
    • Maeda, Makiko;
    • Fujio, Yasushi;
    • Yoshiyama, Minoru
    Publication type:
    Article
    12
    13
    14
    15

    Investigational Therapies and Patients' Autonomy.

    Published in:
    Canadian Journal of Bioethics / Revue canadienne de bioéthique, 2020, v. 3, n. 3, p. 115, doi. 10.7202/1073786ar
    By:
    • Papakonstantinou, Trisevgeni;
    • Kolettis, Theofilos M.
    Publication type:
    Article
    16
    17

    Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.

    Published in:
    2025
    By:
    • Shimizu, Toshio;
    • Powderly, John;
    • Abdul Razak, Albiruni;
    • LoRusso, Patricia;
    • Miller, Kathy D.;
    • Kao, Steven;
    • Kongpachith, Sarah;
    • Tribouley, Catherine;
    • Graham, Michelle;
    • Stoll, Brian;
    • Patel, Maulik;
    • Sahtout, Mohammad;
    • Blaney, Martha;
    • Leibman, Rachel;
    • Golan, Talia;
    • Tolcher, Anthony
    Publication type:
    Correction Notice
    18

    First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1376551
    By:
    • Shimizu, Toshio;
    • Powderly, John;
    • Abdul Razak, Albiruni;
    • LoRusso, Patricia;
    • Miller, Kathy D.;
    • Kao, Steven;
    • Kongpachith, Sarah;
    • Tribouley, Catherine;
    • Graham, Michelle;
    • Stoll, Brian;
    • Patel, Maulik;
    • Sahtout, Mohammad;
    • Blaney, Martha;
    • Leibman, Rachel;
    • Golan, Talia;
    • Tolcher, Anthony
    Publication type:
    Article
    19

    First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1376551
    By:
    • Shimizu, Toshio;
    • Powderly, John;
    • Abdul Razak, Albiruni;
    • LoRusso, Patricia;
    • Miller, Kathy D.;
    • Kao, Steven;
    • Kongpachith, Sarah;
    • Tribouley, Catherine;
    • Graham, Michelle;
    • Stoll, Brian;
    • Patel, Maulik;
    • Sahtout, Mohammad;
    • Blaney, Martha;
    • Leibman, Rachel;
    • Golan, Talia;
    • Tolcher, Anthony
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 96, n. 1, p. 115, doi. 10.1007/s11060-009-0058-3
    By:
    • Olson, Jeffrey;
    • Paleologos, Nina;
    • Gaspar, Laurie;
    • Robinson, Paula;
    • Morris, Rachel;
    • Ammirati, Mario;
    • Andrews, David;
    • Asher, Anthony;
    • Burri, Stuart;
    • Cobbs, Charles;
    • Kondziolka, Douglas;
    • Linskey, Mark;
    • Loeffler, Jay;
    • McDermott, Michael;
    • Mehta, Minesh;
    • Mikkelsen, Tom;
    • Patchell, Roy;
    • Ryken, Timothy;
    • Kalkanis, Steven
    Publication type:
    Article
    30
    31
    32

    A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint.

    Published in:
    Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01014-8
    By:
    • Bever, Katherine M.;
    • Thomas II, Dwayne L.;
    • Zhang, Jiajia;
    • Diaz Rivera, Ernie A.;
    • Rosner, Gary L.;
    • Zhu, Qingfeng;
    • Nauroth, Julie M.;
    • Christmas, Brian;
    • Thompson, Elizabeth D.;
    • Anders, Robert A.;
    • Judkins, Carol;
    • Liu, Meizheng;
    • Jaffee, Elizabeth M.;
    • Ahuja, Nita;
    • Zheng, Lei;
    • Azad, Nilofer S.
    Publication type:
    Article
    33
    34
    35

    Current status and research directions in acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01143-2
    By:
    • Kantarjian, Hagop;
    • Borthakur, Gautam;
    • Daver, Naval;
    • DiNardo, Courtney D.;
    • Issa, Ghayas;
    • Jabbour, Elias;
    • Kadia, Tapan;
    • Sasaki, Koji;
    • Short, Nicholas J.;
    • Yilmaz, Musa;
    • Ravandi, Farhad
    Publication type:
    Article
    36
    37
    38

    A Decision Support Framework for Genomically Informed Investigational Cancer Therapy.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 7, p. 1, doi. 10.1093/jnci/djv098
    By:
    • Meric-Bernstam, Funda;
    • Johnson, Amber;
    • Holla, Vijaykumar;
    • Bailey, Ann Marie;
    • Brusco, Lauren;
    • Chen, Ken;
    • Routbort, Mark;
    • Patel, Keyur P.;
    • Zeng, Jia;
    • Kopetz, Scott;
    • Davies, Michael A.;
    • Piha-Paul, Sarina A.;
    • Hong, David S.;
    • Eterovic, Agda Karina;
    • Tsimberidou, Apostolia M.;
    • Broaddus, Russell;
    • Bernstam, Elmer V.;
    • Shaw, Kenna R.;
    • Mendelsohn, John;
    • Mills, Gordon B.
    Publication type:
    Article
    39

    A decision support framework for genomically informed investigational cancer therapy.

    Published in:
    2015
    By:
    • Meric-Bernstam, Funda;
    • Johnson, Amber;
    • Holla, Vijaykumar;
    • Bailey, Ann Marie;
    • Brusco, Lauren;
    • Chen, Ken;
    • Routbort, Mark;
    • Patel, Keyur P;
    • Zeng, Jia;
    • Kopetz, Scott;
    • Davies, Michael A;
    • Piha-Paul, Sarina A;
    • Hong, David S;
    • Eterovic, Agda Karina;
    • Tsimberidou, Apostolia M;
    • Broaddus, Russell;
    • Bernstam, Elmer V;
    • Shaw, Kenna R;
    • Mendelsohn, John;
    • Mills, Gordon B
    Publication type:
    journal article
    40

    Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11493-2
    By:
    • Reitman, Zachary J.;
    • Paolella, Brenton R.;
    • Bergthold, Guillaume;
    • Pelton, Kristine;
    • Becker, Sarah;
    • Jones, Robert;
    • Sinai, Claire E.;
    • Malkin, Hayley;
    • Huang, Ying;
    • Grimmet, Leslie;
    • Herbert, Zachary T.;
    • Sun, Yu;
    • Weatherbee, Jessica L.;
    • Alberta, John A.;
    • Daley, John F.;
    • Rozenblatt-Rosen, Orit;
    • Condurat, Alexandra L.;
    • Qian, Kenin;
    • Khadka, Prasidda;
    • Segal, Rosalind A.
    Publication type:
    Article
    41
    42
    43
    44

    Adjuvant chemotherapy for colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.

    Published in:
    Annals of Gastroenterology, 2016, v. 29, n. 1, p. 18
    By:
    • Kountourakis, Panteleimon;
    • Souglakos, John;
    • Gouvas, Nikolaos;
    • Androulakis, Nikolaos;
    • Athanasiadis, Athanasios;
    • Boukovinas, Ioannis;
    • Christodoulou, Christos;
    • Chrysou, Evangelia;
    • Dervenis, Christos;
    • Emmanouilidis, Christos;
    • Georgiou, Panagiotis;
    • Karachaliou, Niki;
    • Katopodi, Ourania;
    • Makatsoris, Thomas;
    • Papakostas, Pavlos;
    • Pentheroudakis, Georgios;
    • Pilpilidis, Ioannis;
    • Sgouros, Joseph;
    • Tekkis, Paris;
    • Triantopoulou, Charina
    Publication type:
    Article
    45
    46
    47
    48
    49
    50